In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Lung cancer disproportionately affects Black communities. Discover the causes, risk factors, and prevention strategies to ...

Scientists have found that a test to detect circulating tumor DNA can predict lung cancer outcome. Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to ...

Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to ...

Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.

The current work delves into the role of ING5, a member of the ING tumor suppressor family, in regulating this metabolic reprogramming in lung cancer cells. The study uncovers a novel mechanism by ...

A recent study uncovers how drug-resistant cancer cells induce changes in the tumor microenvironment. This phenomenon ...